NFA
IMDZ

Nationwide Fund Advisors’s Immune Design Corp. IMDZ Stock Holding History

Nationwide Fund Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-133,509
Closed -$1.38M – 3137
2017
Q3 		$1.38M Sell
133,509
-4,200
-3% -$41.3K 0.01% 1616
2017
Q2 		$1.34M Buy
137,709
+127,100
+1,198% +$892K 0.01% 1612
2017
Q1 		$72K Sell
10,609
-500
-5% -$2.89K ﹤0.01% 2920
2016
Q4 		$61K Sell
11,109
-200
-2% -$1.41K ﹤0.01% 2981
2016
Q3 		$86K Buy
11,309
+931
+9% +$6.81K ﹤0.01% 2939
2016
Q2 		$85K Sell
10,378
-200
-2% -$2.49K ﹤0.01% 2975
2016
Q1 		$138K Hold
10,578
– – ﹤0.01% 2701
2015
Q4 		$212K Sell
10,578
-24,630
-70% -$424K ﹤0.01% 2524
2015
Q3 		$430K Sell
35,208
-1,920
-5% -$36K ﹤0.01% 2203
2015
Q2 		$767K Buy
37,128
+12,379
+50% +$292K ﹤0.01% 2020
2015
Q1 		$522K Buy
24,749
+10,650
+76% +$278K ﹤0.01% 2213
2014
Q4 		$434K Buy
14,099
+2,091
+17% +$58.1K ﹤0.01% 2263
2014
Q3 		$212K Buy
+12,008
New +$152K ﹤0.01% 2661

Other funds holding IMDZ

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nationwide Fund Advisors's IMDZ Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Immune Design Corp. (IMDZ) in Q4 2017, closing a stake of 133,509 shares — an estimated $1.38M sold.

Nationwide Fund Advisors first reported a position in IMDZ in Q3 2014 and held it in 13 quarters. The position peaked at $1.38M in Q3 2017. 76 funds tracked by Wall St. Rank hold IMDZ as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Immune Design Corp. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 133,509 Immune Design Corp. shares in Q4 2017, an estimated $1.38M.
  • Nationwide Fund Advisors first reported a position in Immune Design Corp. in Q3 2014 and held it in 13 quarters.
  • Nationwide Fund Advisors's Immune Design Corp. position peaked at $1.38M in Q3 2017.
  • 76 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.